Tezepelumab for severe asthma

Institute for Clinical and Economic Review (ICER)
Record ID 32018002628
Project Status: Completed
Year Published: 2021
URL for published report: https://icer.org/asthma-2021/#timeline
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Asthma
  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • Cost-Benefit Analysis
Organisation Name: Institute for Clinical and Economic Review
Contact Address: 101 Merrimac St., 10th FL., Boston MA, USA 02114, Tel: (617) 724-4445 , Fax: (617) 726-9414
Contact Name: info@icer-review.org
Contact Email: info@icer-review.org
Copyright: <p>Institute for Clinical and Economic Review (ICER)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.